FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Margaret Fischl

Research Profile

Disorders

Chemicals & Drugs

Living Beings

HIV-1

Procedures

Concepts & Ideas

Anatomy

CD4-Positive T-Lymphocytes

Co-author Network

Publications

TOP 3
Heather J Ribaudo; Paul E Sax; Camlin Tierney; Ann C Collier; Eric S Daar; Margaret A Fischl; David W Haas; Katie Mollan; Gene D Morse
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.
Katie Mollan; Paul E Sax; Camlin Tierney; Maya Balamane; Ronald J Bosch; Ann C Collier; Eric S Daar; Margaret A Fischl; David Katzenstein; Christina M Lalama
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.
Suresh Pallikkuth; Anita Parmigiani; Sandra Y Silva; Margaret A Fischl; Varghese K George; Rajendra Pahwa; Savita Pahwa
Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Margaret Fischl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Heather J Ribaudo; Paul E Sax; Camlin Tierney; Ann C Collier; Eric S Daar; Margaret A Fischl; David W Haas; Katie Mollan; Gene D Morse
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.
The Journal of infectious diseases 2013;207(3):420-5.
2012: Katie Mollan; Paul E Sax; Camlin Tierney; Maya Balamane; Ronald J Bosch; Ann C Collier; Eric S Daar; Margaret A Fischl; David Katzenstein; Christina M Lalama
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.
The Journal of infectious diseases 2012;206(12):1920-30.
2012: Suresh Pallikkuth; Anita Parmigiani; Sandra Y Silva; Margaret A Fischl; Varghese K George; Rajendra Pahwa; Savita Pahwa
Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine.
Blood 2012;120(5):985-93.
2012: Y Lévy; J M Molina; Michel MORRE; J F Poulin; B Rodriguez; J P Routy; C Rouzioux; R P Sekaly; I Sereti; G Tambussi; R Thiebaut; V Avettand-Fenoël; Stéphanie Beq; T Croughs; J F Delfraissy; Margaret A Fischl; C Goujard; J D Lelièvre; M M Lederman
Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(2):291-300.
2011: Suresh Pallikkuth; Sandra Y Silva; Margaret A Fischl; Sudheesh Pilakka Kanthikeel; Rajendra Pahwa; Savita Pahwa
Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients.
The Journal of allergy and clinical immunology 2011;128(6):1279-85.
2011: Paul E Sax; Karen Tashima; Camlin Tierney; William C Woodward; Chakra Budhathoki; Ann C Collier; Eric S Daar; Awny Farajallah; Judith Feinberg; Margaret A Fischl; Catherine Godfrey; Belinda Ha; Nasreen C Jahed; David Katzenstein; Katie Mollan; Robert L Murphy; Laurie Myers; James F Rooney
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.
The Journal of infectious diseases 2011;204(8):1191-201.
2011: Qing Ma; Charles S Venuto; Barry S Zingman; Robin DiFrancesco; Margaret A Fischl; Alan Forrest; Barbara Gripshover; Amneris E Luque; Gene D Morse
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.
Therapeutic drug monitoring 2011;33(3):309-14.
2011: Suresh Pallikkuth; Sudheesh Pilakka Kanthikeel; Sandra Y Silva; Margaret A Fischl; Rajendra Pahwa; Savita Pahwa
Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy.
Journal of immunology (Baltimore, Md. : 1950) 2011;186(11):6173-81.
2011: Eric S Daar; Camlin Tierney; Margaret A Fischl; Paul E Sax; Katie Mollan; Chakra Budhathoki; Catherine Godfrey; Nasreen C Jahed; Laurie Myers; David Katzenstein; Awny Farajallah; James F Rooney; Keith A Pappa; William C Woodward; Kristine Patterson; Hector Bolivar; Constance A Benson; Ann C Collier
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
Annals of internal medicine 2011;154(7):445-56.
2011: Liguo Niu; James M Termini; Saravana K Kanagavelu; Sachin Gupta; Morgane M Rolland; Viraj Kulkarni; George N Pavlakis; Barbara K Felber; James I Mullins; Margaret A Fischl; Geoffrey Stone
Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
Vaccine 2011;29(11):2110-9.
2011: Hiromi Imamichi; Gerald Degray; David M Asmuth; Margaret A Fischl; Alan L Landay; Michael M Lederman; Irini Sereti
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy.
AIDS (London, England) 2011;25(2):159-64.
2010: Scott M Hammer; Heather Ribaudo; Roland Bassett; John W Mellors; Lisa M Demeter; Robert W Coombs; Judith Currier; Gene D Morse; John G Gerber; Ana I Martinez; William Spreen; Margaret A Fischl; Kathleen E Squires
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.
HIV clinical trials 2010;11(6):312-24.
2010: Meenakshi Sachdeva; Margaret A Fischl; Rajendra Pahwa; Naresh Sachdeva; Savita Pahwa
Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2010;54(5):447-54.
2010: Lisa L Ross; Winkler G Weinberg; Edwin DeJesus; Margaret A Fischl; Joseph H Horton; Keith A Pappa; Charles Tracey Lancaster; Gary E Pakes; Kimberly Y Smith
Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients.
AIDS research and human retroviruses 2010;26(4):407-17.
2009: Paul E Sax; Camlin Tierney; Ann C Collier; Margaret A Fischl; Katie Mollan; Lynne Peeples; Catherine Godfrey; Nasreen C Jahed; Laurie Myers; David Katzenstein; Awny Farajallah; James F Rooney; Belinda Ha; William C Woodward; Susan L Koletar; Victoria A Johnson; P Jan Geiseler; Eric S Daar
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
The New England journal of medicine 2009;361(23):2230-40.
2009: Hector Bolivar; Rebeca Benzaquen Geffin; Gabriel Manzi; Margaret A Fischl; Vera Holzmayer; Wai-Bing Mak; Klara Abravaya; John Hackett
The challenge of HIV-1 genetic diversity: discordant CD4+ T-Cell count and viral load in an untreated patient infected with a subtype F strain.
Journal of acquired immune deficiency syndromes (1999) 2009;52(5):659-61.
2009: Irini Sereti; Richard M Dunham; John Spritzler; Evgenia Aga; Michael A Proschan; Kathy Medvik; Catherine A Battaglia; Alan L Landay; Savita Pahwa; Margaret A Fischl; David M Asmuth; Allan Tenorio; John D Altman; Lawrence Fox; Susan Moir; Angela Malaspina; Michel MORRE; Renaud Buffet; Guido Silvestri; Michael M Lederman
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
Blood 2009;113(25):6304-14.
2008: Jeffrey M Jacobson; Michael S Saag; Melanie A Thompson; Margaret A Fischl; Ralph Liporace; Richard C Reichman; Robert R Redfield; Carl J Fichtenbaum; Barry S Zingman; Mahesh C Patel; Jose D Murga; Suzanne M Pemrick; Paul D'Ambrosio; Marti Michael; Hans Kroger; Hieu Ly; Yakov Rotshteyn; Robert Buice; Stephen A Morris; Joseph J Stavola; Paul J Maddon; Alton B Kremer; William C Olson
Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.
The Journal of infectious diseases 2008;198(9):1345-52.
2008: Scott M Hammer; Joseph J Eron; Peter Reiss; Robert T Schooley; Melanie A Thompson; Sharon Walmsley; Pedro Cahn; Margaret A Fischl; Jose M Gatell; Martin S Hirsch; Donna M Jacobsen; Julio S G Montaner; Douglas D Richman; Patrick G Yeni; Paul A Volberding
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2008;300(5):555-70.
2008: Kimberly Y Smith; Winkler G Weinberg; Edwin Dejesus; Margaret A Fischl; Qiming Liao; Lisa L Ross; Gary E Pakes; Keith A Pappa; Charles Tracey Lancaster
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
AIDS research and therapy 2008;5():5.
2008: Lisa M Demeter; Victor DeGruttola; Stephanie Lustgarten; Daniel Bettendorf; Margaret A Fischl; Susan H Eshleman; William Spreen; Bach-Yen Nguyen; Christine E Koval; Joseph J Eron; Scott Hammer; Kathleen Squires
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience.
HIV clinical trials 2008;9(1):11-25.
2007: Niamh Higgins; Barry S Zingman; Judianne C Slish; Richard C Reichman; Margaret A Fischl; Barbara Gripshover; Kelly Tooley; Naomi Boston; Alan Forrest; Daniel A Brazeau; Linda M Catanzaro; Robin DiFrancesco; Francesco Lliguicota; Qing Ma; Gene D Morse
Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2007;16(6):488-94.
2007: Judianne C Slish; Qing Ma; Barry S Zingman; Richard C Reichman; Margaret A Fischl; Barbara Gripshover; Alan Forrest; Daniel A Brazeau; Naomi S Boston; Linda M Catanzaro; Robin DiFrancesco; Gene D Morse
Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring.
Therapeutic drug monitoring 2007;29(5):560-5.
2007: William D King; Donna M DeFreitas; Kimberly Smith; Janet Andersen; Lisa Patton Perry; Toyin Adeyemi; Jennifer Mitty; Jan Fritsche; Carrie Jeffries; Melvin Littles; Margaret A Fischl; Gregory Pavlov; Donna Mildvan
Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: a descriptive study.
AIDS patient care and STDs 2007;21(8):551-63.
2007: Pablo Tebas; Jiameng Zhang; Kevin E Yarasheski; Scott Evans; Margaret A Fischl; Abby Shevitz; Judith Feinberg; Ann C Collier; Cecilia M Shikuma; Barbara Brizz; Fred R Sattler
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).
Journal of acquired immune deficiency syndromes (1999) 2007;45(2):193-200.
2007: Robin DiFrancesco; Margaret A Fischl; Julie Donnelly; Barry S Zingman; Elinore F McCance-Katz; David E Moody; Richard C Reichman; Barbara Gripshover; Gene D Morse
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
Journal of pharmaceutical and biomedical analysis 2007;44(1):188-95.
2007: Qing Ma; Daniel A Brazeau; Barry S Zingman; Richard C Reichman; Margaret A Fischl; Barbara Gripshover; Charles S Venuto; Judianne C Slish; Robin DiFrancesco; Alan Forrest; Gene D Morse
Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.
Pharmacogenomics 2007;8(3):227-35.
2007: Kim Keil; Jill Hochreitter; Robin DiFrancesco; Barry S Zingman; Richard C Reichman; Margaret A Fischl; Barbara Gripshover; Gene D Morse
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.
Therapeutic drug monitoring 2007;29(1):103-9.
2007: Margaret A Fischl; Ann C Collier; A Lisa Mukherjee; Judith E Feinberg; Lisa M Demeter; Pablo Tebas; Marina Giuliano; Marjorie Dehlinger; Kevin Garren; Barbara Brizz; Roland Bassett
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen.
AIDS (London, England) 2007;21(3):325-33.
2007: Jeff D Moore; Edward P Acosta; Victoria A Johnson; Roland Bassett; Joseph J Eron; Margaret A Fischl; Mary C Long; Daniel R Kuritzkes; Jean-Pierre Sommadossi
Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
Antiviral therapy 2007;12(6):981-6.
2006: J. Michael Kilby; R Pat Bucy; Donna Mildvan; Margaret A Fischl; Jorge Santana-Bagur; Jeffrey Lennox; Christopher D Pilcher; Andrew R Zolopa; Jody Lawrence; Richard B Pollard; Raphaelle El Habib; David Sahner; Lawrence Fox; Evgenia Aga; Ronald J Bosch; Ronald T Mitsuyasu
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).
The Journal of infectious diseases 2006;194(12):1672-6.
2006: Scott M Hammer; Michael S Saag; Mauro Schechter; Julio S G Montaner; Robert T Schooley; Donna M Jacobsen; Melanie A Thompson; Charles C J Carpenter; Margaret A Fischl; Brian G Gazzard; José M Gatell; Martin S Hirsch; David A Katzenstein; Douglas D Richman; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2006;296(7):827-43.
2006: Scott M Hammer; Michael S Saag; Mauro Schechter; Julio S G Montaner; Robert T Schooley; Donna M Jacobsen; Melanie A Thompson; Charles C J Carpenter; Margaret A Fischl; Brian G Gazzard; José M Gatell; Martin S Hirsch; David A Katzenstein; Douglas D Richman; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2006;14(3):827-43.
2006: Susan E Krown; Jeannette Y Lee; Lan Lin; Margaret A Fischl; Richard F Ambinder; Jamie H Von Roenn
Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.
Journal of acquired immune deficiency syndromes (1999) 2006;41(2):149-53.
2005: Ann C Collier; Heather J Ribaudo; A Lisa Mukherjee; Judith Feinberg; Margaret A Fischl; Margaret A Chesney
A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy.
The Journal of infectious diseases 2005;192(8):1398-406.
2005: Patrick F Smith; Gregory Robbins; Robert W Shafer; Hulin Wu; Song Yu; Martin S Hirsch; Thomas C Merigan; Jeong-Gun Park; Alan Forrest; Margaret A Fischl; Gene D Morse
Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitors.
Antimicrobial agents and chemotherapy 2005;49(8):3558-61.
2005: Patrick F Smith; Robert DiCenzo; Alan Forrest; Mark J Shelton; Gerald Friedland; Michael F Para; Richard B Pollard; Margaret A Fischl; Robin DiFrancesco; Gene D Morse
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals.
Clinical pharmacokinetics 2005;44(1):99-109.
2004: Lisa M Demeter; Heather J Ribaudo; Alejo Erice; Susan H Eshleman; Scott M Hammer; Nicholas S Hellmann; Margaret A Fischl
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(4):552-8.
2004: Patrick G Yeni; Scott M Hammer; Martin S Hirsch; Michael S Saag; Mauro Schechter; Charles C J Carpenter; Margaret A Fischl; José M Gatell; Brian G Gazzard; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Paul A Volberding
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2004;292(2):251-65.
2004: Robert DiCenzo; Alan Forrest; Margaret A Fischl; Ann Collier; Judith Feinberg; Heather J Ribaudo; Robin DiFrancecso; Gene D Morse
Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjects.
Antimicrobial agents and chemotherapy 2004;48(3):918-23.
2004: Uma Malhotra; Ronald J Bosch; Ellen Chan; Rui Wang; Margaret A Fischl; Ann C Collier; M Juliana McElrath
Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease.
The Journal of infectious diseases 2004;189(3):515-9.
2003: Gregory Robbins; Victor De Gruttola; Robert W Shafer; Laura M Smeaton; Snyder Sally; Carla Pettinelli; Michael P Dubé; Margaret A Fischl; Richard B Pollard; Robert Delapenha; Linda Gedeon; Charles van der Horst; Robert L Murphy; Mark I Becker; Richard T D'Aquila; STEFANO VELLA; Thomas C Merigan; Martin S Hirsch
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.
The New England journal of medicine 2003;349(24):2293-303.
2003: Scott M Hammer; Roland Bassett; Kathleen E Squires; Margaret A Fischl; Lisa M Demeter; Judith S Currier; John W Mellors; Gene D Morse; Joseph J Eron; Jorge L Santana; Victor DeGruttola
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.
Antiviral therapy 2003;8(6):507-18.
2003: Margaret A Fischl; Alfred E Burnside; Charles E Farthing; Melanie A Thompson; Nicholaos C Bellos; Vanessa C Williams; Teresa L Kauf; Paul G Wannamaker; Mark Shaefer
Twice-daily Trizivir versus Combivir-abacavir in antiretroviral-experienced adults with human immunodeficiency virus-1 infection: a formulation-switch trial.
Pharmacotherapy 2003;23(11):1432-40.
2003: Martin S Hirsch; Roy T Steigbigel; Scholomo Staszewski; Deborah McMahon; Margaret A Fischl; Bernard Hirschel; Kathleen E Squires; Mark J DiNubile; Charlotte M Harvey; Joshua Chen; Randi Y Leavitt
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(8):1119-24.
2003: Margaret A Fischl; Heather J Ribaudo; Ann C Collier; Alejo Erice; Marina Giuliano; Marjorie Dehlinger; Joseph J Eron; Michael S Saag; Scott M Hammer; STEFANO VELLA; Gene D Morse; Judith E Feinberg; Lisa M Demeter; Susan H Eshleman
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.
The Journal of infectious diseases 2003;188(5):625-34.
2003: Robert DiCenzo; Alan Forrest; Kathleen E Squires; Scott M Hammer; Margaret A Fischl; Hulin Wu; Raymond Cha; Gene D Morse
Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjects.
Antimicrobial agents and chemotherapy 2003;47(6):1929-35.
2003: G L Daikos; Timothy Cleary; Allan Rodriguez; Margaret A Fischl
Multidrug-resistant tuberculous meningitis in patients with AIDS.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2003;7(4):394-8.
2003: Gene D Morse; Margaret A Fischl; Mark J Shelton; Steve R Cox; Leslie Thompson; Andrew A Della-Coletta; William W Freimuth
Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection.
Clinical drug investigation 2003;23(4):255-61.
2002: Benjamin Young; Margaret A Fischl; Helene M Wilson; Tyler S Finn; Erin Jensen; Mark J DiNubile; Robert K Zeldin
Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults.
Journal of acquired immune deficiency syndromes (1999) 2002;31(5):478-82.
2002: Roy M Gulick; X Joan Hu; Susan A Fiscus; Courtney V Fletcher; Richard Haubrich; Hailong Cheng; Edward Acosta; Stephen W Lagakos; Ronald Swanstrom; William Freimuth; Snyder Sally; Charlotte Mills; Margaret A Fischl; Carla Pettinelli; David Katzenstein
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359.
The Journal of infectious diseases 2002;186(5):626-33.
2002: Patrick G Yeni; Scott M Hammer; Charles C J Carpenter; David A Cooper; Margaret A Fischl; José M Gatell; Brian G Gazzard; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Mauro Schechter; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Paul A Volberding
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2002;288(2):222-35.
2002: Lisa M Demeter; Ronald J Bosch; Robert W Coombs; Susan A Fiscus; James Bremer; Victoria A Johnson; Alejo Erice; J Brooks Jackson; Stephen A Spector; Kathleen M Squires; Margaret A Fischl; Michael D Hughes; Scott M Hammer
Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.
Journal of clinical microbiology 2002;40(6):2089-94.
2002: Mounir Ait-Khaled; Abdelrahim Rakik; Philip Griffin; Amy Cutrell; Margaret A Fischl; Nathan Clumeck; Stephen B Greenberg; Rafael Rubio; Barry S Peters; Federico Pulido; Jayne Gould; Gillian Pearce; William Spreen; Margaret Tisdale; Steve Lafon
Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy.
Antiviral therapy 2002;7(1):43-51.
2002: Larry R Kirkland; Margaret A Fischl; Karen T Tashima; David Paar; Thomas Gensler; Neil M Graham; Haitao Gao; Jacqueline R Carranza Rosenzweig; Daniel R McClernon; Ginger Pittman; Siegrid M Hessenthaler; Jaime E Hernandez
Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(4):511-8.
2001: Lisa M Demeter; Michael D Hughes; Robert W Coombs; J Brooks Jackson; J M Grimes; Ronald J Bosch; Susan A Fiscus; Stephen A Spector; Kathleen E Squires; Margaret A Fischl; Scott M Hammer
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.
Annals of internal medicine 2001;135(11):954-64.
2001: J M Arduino; Margaret A Fischl; Kenneth Stanley; Ann C Collier; D Spiegelman
Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
AIDS research and human retroviruses 2001;17(12):1099-105.
2001: W Huang; Victor De Gruttola; Margaret A Fischl; S Hammer; Douglas Richman; Diane V Havlir; Roy M Gulick; Kathleen E Squires; John Mellors
Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy.
The Journal of infectious diseases 2001;183(10):1455-65.
2000: Margaret A Fischl
Clinical trials within the Florida Department of Corrections.
Medicine and health, Rhode Island 2000;83(12):393.
2000: Courtney V Fletcher; Edward P Acosta; Hailong Cheng; Richard Haubrich; Margaret A Fischl; Ralph H Raasch; Charlotte Mills; X Joan Hu; David Katzenstein; R P Remmel; Roy M Gulick
Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884.
AIDS (London, England) 2000;14(16):2495-501.
2000: Roy M Gulick; X Joan Hu; Susan A Fiscus; Courtney V Fletcher; Richard Haubrich; Hailong Cheng; Edward Acosta; Stephen W Lagakos; Ronald Swanstrom; William Freimuth; Snyder Sally; Charlotte Mills; Margaret A Fischl; C Pettinelli; David Katzenstein
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359.
The Journal of infectious diseases 2000;182(5):1375-84.
2000: J C Goodgame; J C Pottage; H Jablonowski; W D Hardy; A Stein; Margaret A Fischl; P Morrow; J Feinberg; C H Brothers; I Vafidis; P Nacci; Jane Yeo; L Pedneault
Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team.
Antiviral therapy 2000;5(3):215-25.
2000: Lisa M Demeter; R W Shafer; PM Meehan; J Holden-Wiltse; Margaret A Fischl; William Freimuth; Michael F Para; Richard C Reichman
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260).
Antimicrobial agents and chemotherapy 2000;44(3):794-7.
2000: Charles C J Carpenter; D A Cooper; Margaret A Fischl; José M Gatell; Brian G Gazzard; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Mauro Schechter; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2000;283(3):381-90.
2000: G D Morse; Richard C Reichman; Margaret A Fischl; Michael F Para; J Leedom; William G Powderly; L M Demeter; L Resnick; Y Bassiakos; J Timpone; S Cox; D Batts
Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams.
Antiviral research 2000;45(1):47-58.
1999: Margaret A Fischl
Antiretroviral therapy in 1999 for antiretroviral-naive individuals with HIV infection.
AIDS (London, England) 1999;13 Suppl 1():S49-59.
1999: Gerald Friedland; Richard B Pollard; B Griffith; M Hughes; Gene D Morse; Roland Bassett; William Freimuth; Lisa M Demeter; E Connick; T Nevin; M Hirsch; Margaret A Fischl
Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team.
Journal of acquired immune deficiency syndromes (1999) 1999;21(4):281-92.
1999: Michael F Para; PM Meehan; J Holden-Wiltse; Margaret A Fischl; Gene D Morse; Robert Shafer; Lisa M Demeter; K Wood; T Nevin; N Virani-Ketter; William Freimuth
ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy. The AIDS Clinical Trials Group Protocol 260 Team.
Antimicrobial agents and chemotherapy 1999;43(6):1373-8.
1999: Daniel R Kuritzkes; Ian C Marschner; Victoria A Johnson; Roland Bassett; Joseph J Eron; Margaret A Fischl; Robert L Murphy; K Fife; J Maenza; ME Rosandich; Dawn Bell; K Wood; Jean-Pierre Sommadossi; Carla Pettinelli
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Investigators.
AIDS (London, England) 1999;13(6):685-94.
1999: XJ Zhou; L B Sheiner; Richard T D'Aquila; Michael D Hughes; M S Hirsch; Margaret A Fischl; Victoria A Johnson; M Myers; Jean-Pierre Sommadossi
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
Antimicrobial agents and chemotherapy 1999;43(1):121-8.
1998: Keith Henry; Alejo Erice; Camlin Tierney; Henry H Balfour; Margaret A Fischl; A Kmack; S H Liou; A Kenton; Martin S Hirsch; J Phair; A Martinez; J O Kahn
A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(4):339-49.
1998: Michael D Hughes; M J Daniels; Margaret A Fischl; S Kim; Robert T Schooley
CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group.
AIDS (London, England) 1998;12(14):1823-32.
1998: Lisa M Demeter; PM Meehan; Gene D Morse; Margaret A Fischl; Michael F Para; William G Powderly; J Leedom; J Holden-Wiltse; C Greisberger; K Wood; J Timpone; L K Wathen; T Nevin; L Resnick; D H Batts; Richard C Reichman
Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(2):135-44.
1998: G L Daikos; R B Uttamchandani; Claudio Tuda; Margaret A Fischl; N Miller; Timothy Cleary; M J Saldana
Disseminated miliary tuberculosis of the skin in patients with AIDS: report of four cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(1):205-8.
1998: Donald W Northfelt; Bruce J Dezube; J A Thommes; B J Miller; Margaret A Fischl; Alvin Friedman-Kien; Lawrence D Kaplan; C Du Mond; RD Mamelok; D H Henry
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2445-51.
1998: Charles C J Carpenter; Margaret A Fischl; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 1998;280(1):78-86.
1998: Robert Zackin; Ian C Marschner; J Andersen; M K Cowles; Victor De Gruttola; S Hammer; Margaret A Fischl; Deborah Cotton
Perspective: human immunodeficiency virus type 1 (HIV-1) RNA end points in HIV clinical trials: issues in interim monitoring and early stopping.
The Journal of infectious diseases 1998;177(3):761-5.
1998: Ian C Marschner; Ann C Collier; Robert W Coombs; Richard T D'Aquila; Victor DeGruttola; Margaret A Fischl; Scott M Hammer; Michael D Hughes; Victoria A Johnson; David A Katzenstein; Douglas D Richman; Laura M Smeaton; Stephen A Spector; M S Saag
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.
The Journal of infectious diseases 1998;177(1):40-7.
1997: Margaret A Fischl; D D Richman; M Saag; T C Meng; Kathleen E Squires; J Holden-Wiltse; PM Meehan
Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(4):247-53.
1997: Scott M Hammer; Kathleen E Squires; Michael D Hughes; J M Grimes; Lisa M Demeter; Judith S Currier; Joseph J Eron; Judith E Feinberg; Henry H Balfour; L R Deyton; J A Chodakewitz; Margaret A Fischl
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
The New England journal of medicine 1997;337(11):725-33.
1997: Q J Qayyum; Ernesto Scerpella; Jose N Moreno; Margaret A Fischl
Report of 24 cases of Listeria monocytogenes infection at the University of Miami Medical Center.
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1997;49(4):265-70.
1997: Charles C J Carpenter; Margaret A Fischl; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 1997;277(24):1962-9.
1997: Michael D Hughes; Victoria A Johnson; Martin S Hirsch; J W Bremer; T Elbeik; Alejo Erice; Daniel R Kuritzkes; Walter A Scott; Stephen A Spector; Nesli Basgoz; Margaret A Fischl; Richard T D'Aquila
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
Annals of internal medicine 1997;126(12):929-38.
1997: Margaret A Fischl; D D Richman; Charles Flexner; Michael F Para; R Haubrich; A Karim; P Yeramian; J Holden-Wiltse; PM Meehan
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(1):28-34.
1997: David M Simpson; P Slasor; U Dafni; J Berger; Margaret A Fischl; Colin D Hall
Analysis of myopathy in a placebo-controlled zidovudine trial.
Muscle & nerve 1997;20(3):382-5.
1997: Gene D Morse; Margaret A Fischl; Mark J Shelton; Steve R Cox; M Driver; M DeRemer; William Freimuth
Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection.
Antimicrobial agents and chemotherapy 1997;41(1):169-74.
1996: Seth Welles; J Brooks Jackson; Belinda Yen-Lieberman; Lisa M Demeter; AJ Japour; Laura M Smeaton; Victoria A Johnson; Daniel R Kuritzkes; Richard T D'Aquila; P A Reichelderfer; Douglas D Richman; Richard C Reichman; Margaret A Fischl; R Dolin; Robert W Coombs; J O Kahn; C McLaren; J Todd; S Kwok; Clyde S Crumpacker
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.
The Journal of infectious diseases 1996;174(4):696-703.
1996: Eric Lorenzo; Rene J Herrera; Shenghan Lai; Margaret A Fischl; M D Hill
The Tat and C2-V3 envelope genes in the molecular epidemiology of human immunodeficiency virus-1.
Virology 1996;221(2):310-7.
1996: Charles C J Carpenter; Margaret A Fischl; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; J S Montaner; Douglas D Richman; M S Sáag; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.
JAMA : the journal of the American Medical Association 1996;276(2):146-54.
1996: Richard T D'Aquila; Michael D Hughes; Victoria A Johnson; Margaret A Fischl; Jean-Pierre Sommadossi; S H Liou; J Timpone; M Myers; Nesli Basgoz; M Niu; Martin S Hirsch
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
Annals of internal medicine 1996;124(12):1019-30.
1996: Donna Mildvan; Y Bassiakos; M L Zucker; N Hyslop; Susan E Krown; H S Sacks; J Zachary; J Paredes; W J Fessel; F Rhame; F Kramer; Margaret A Fischl; B Poiesz; K Wood; Ruth Ruprecht; J Kim; S E Grossberg; P Kasdan; P Bergé; A Marshak; Carla Pettinelli
Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068.
Antiviral therapy 1996;1(2):77-88.
1996: Margaret A Fischl; D M Finkelstein; W He; W G Powderly; P L Triozzi; R T Steigbigel
A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(4):379-84.
1996: Gene D Morse; Margaret A Fischl; Mark J Shelton; M T Borin; M R Driver; M DeRemer; K Lee; C P Wajszczuk
Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections.
Antimicrobial agents and chemotherapy 1996;40(3):767-71.
1996: Mark A Jacobson; H Gundacker; M Hughes; Margaret A Fischl; P Volberding
Zidovudine side effects as reported by black, Hispanic, and white/non-Hispanic patients with early HIV disease: combined analysis of two multicenter placebo-controlled trials.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(1):45-52.
1995: M Tierney; J Pottage; H Kessler; Margaret A Fischl; D Richman; T Merigan; W Powderly; S Smith; A Karim; J Sherman
The tolerability and pharmacokinetics of N-butyl-deoxynojirimycin in patients with advanced HIV disease (ACTG 100). The AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and Infectious Diseases.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10(5):549-53.
1995: Paul A Volberding; S W Lagakos; J M Grimes; D S Stein; J Rooney; T C Meng; Margaret A Fischl; Ann C Collier; John Phair; M S Hirsch
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.
The New England journal of medicine 1995;333(7):401-7.
1995: Raphael Dolin; D A Amato; Margaret A Fischl; Carla Pettinelli; M Beltangady; S H Liou; M J Brown; A P Cross; M S Hirsch; W D Hardy
Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group.
Archives of internal medicine 1995;155(9):961-74.
1995: T C Meng; Margaret A Fischl; S H Cheeseman; Stephen A Spector; L Resnick; A Boota; T Petrakis; B Wright; Douglas D Richman
Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;8(2):152-60.
1995: J N Moreno; R B Poblete; C Maggio; S Gagnon; Margaret A Fischl
Rapid oral desensitization for sulfonamides in patients with the acquired immunodeficiency syndrome.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1995;74(2):140-6.
1995: Richard C Reichman; Gene D Morse; Lisa M Demeter; L Resnick; Y Bassiakos; Margaret A Fischl; Michael F Para; W Powderly; J Leedom; C Greisberger
Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.
The Journal of infectious diseases 1995;171(2):297-304.
1995: Margaret A Fischl; K Stanley; Ann C Collier; J M Arduino; D S Stein; J E Feinberg; J D Allan; J C Goldsmith; W G Powderly
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group.
Annals of internal medicine 1995;122(1):24-32.
1994: I Fogelman; L Lim; R Bassett; P Volberding; Margaret A Fischl; K Stanley; Deborah Cotton
Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials. AIDS Clinical Trials Group (ACTG).
Journal of acquired immune deficiency syndromes 1994;7(10):1057-63.
1994: K E Stanley; Margaret A Fischl; A C Collier
Clinical trials: subgroup analyses.
Science (New York, N.Y.) 1994;265(5176):1158.
1994: Victor DeGruttola; Laurel Beckett; Robert W Coombs; J M Arduino; H H Balfour; S Rasheed; F Blaine Hollinger; Margaret A Fischl; P Volberding
Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology Laboratories.
The Journal of infectious diseases 1994;169(4):713-21.
1994: G L Daikos; Shenghan Lai; Margaret A Fischl
Hepatitis C virus infection in a sexually active inner city population. The potential for heterosexual transmission.
Infection 1994;22(2):72-6.
1994: R B Uttamchandani; G L Daikos; R R Reyes; Margaret A Fischl; Gordon M Dickinson; E Yamaguchi; M R Kramer
Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(3):348-53.
1994: Margaret A Fischl; L Resnick; R Coombs; A B Kremer; J C Pottage; Robert J Fass; K H Fife; W G Powderly; Ann C Collier; R L Aspinall
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.
Journal of acquired immune deficiency syndromes 1994;7(2):139-47.
1994: Douglas D Richman; T C Meng; Stephen A Spector; Margaret A Fischl; L Resnick; Shenghan Lai
Resistance to AZT and ddC during long-term combination therapy in patients with advanced infection with human immunodeficiency virus.
Journal of acquired immune deficiency syndromes 1994;7(2):135-8.
1994: Margaret A Fischl
Combination antiretroviral therapy for HIV infection.
Hospital practice (Office ed.) 1994;29(1):43-8.
1993: Ann C Collier; Robert W Coombs; Margaret A Fischl; P R Skolnik; Donald W Northfelt; P Boutin; C J Hooper; Lawrence D Kaplan; P A Volberding; L G Davis; D R Henrard; S Weller; Lawrence Corey
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection.
Annals of internal medicine 1993;119(8):786-93.
1993: G S Liang; G L Daikos; U Serfling; W Y Zhu; M Pecoraro; C L Leonardi; Margaret A Fischl; Neal S Penneys
An evaluation of oral ulcers in patients with AIDS and AIDS-related complex.
Journal of the American Academy of Dermatology 1993;29(4):563-8.
1993: Jerrold Jay Ellner; A R Hinman; S W Dooley; Margaret A Fischl; Kent A Sepkowitz; M J Goldberger; T M Shinnick; M D Iseman; William R. Jacobs Jr.
Tuberculosis symposium: emerging problems and promise.
The Journal of infectious diseases 1993;168(3):537-51.
1993: Danyu Lin; Margaret A Fischl; David Schoenfeld
Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials.
Statistics in medicine 1993;12(9):835-42.
1993: Margaret A Fischl; R M Olson; S E Follansbee; Jacob P Lalezari; D H Henry; P T Frame; S C Remick; M P Salgo; A H Lin; C Nauss-Karol; J Lieberman; W Soo
Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy.
Annals of internal medicine 1993;118(10):762-9.
1993: John J Sidtis; C Gatsonis; R W Price; E J Singer; A C Collier; D D Richman; M S Hirsch; F W Schaerf; Margaret A Fischl; Karl Kieburtz
Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group.
Annals of neurology 1993;33(4):343-9.
1993: Victor De Gruttola; M Wulfsohn; Margaret A Fischl; Anastasios A Tsiatis
Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex.
Journal of acquired immune deficiency syndromes 1993;6(4):359-65.
1993: Margaret A Fischl; Susan E Krown; Kevin P O'Boyle; Ronald T Mitsuyasu; S Miles; J C Wernz; P A Volberding; J Kahn; J E Groopman; J Feinberg
Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
Journal of acquired immune deficiency syndromes 1993;6(3):259-64.
1993: G Skowron; Samuel A Bozzette; L Lim; Carla Pettinelli; Herbert H Schaumburg; Joseph C Arezzo; Margaret A Fischl; W G Powderly; D J Gocke; Douglas D Richman; J Pottage; D Antoniskis; G F McKinley; N E Hyslop; G Ray; G Simon; N Reed; M L LoFaro; R B Uttamchandani; L D Gelb; S J Sperber; R L Murphy; John Leedom; M H Grieco; J Zachary; M S Hirsch; S A Spector; J Bigley; W Soo; Thomas C Merigan
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
Annals of internal medicine 1993;118(5):321-30.
1993: Margaret A Fischl
Treatment of HIV disease in 1993/1994.
AIDS clinical review 1993;():167-87.
1992: D H Henry; G N Beall; C A Benson; J Carey; Lawrence A Cone; L J Eron; Milan Fiala; Margaret A Fischl; S J Gabin; M S Gottlieb
Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
Annals of internal medicine 1992;117(9):739-48.
1992: Margaret A Fischl; G L Daikos; R B Uttamchandani; R B Poblete; J N Moreno; R R Reyes; A M Boota; L M Thompson; Timothy Cleary; S A Oldham
Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli.
Annals of internal medicine 1992;117(3):184-90.
1992: Margaret A Fischl; R B Uttamchandani; G L Daikos; R B Poblete; J N Moreno; R R Reyes; A M Boota; L M Thompson; Timothy Cleary; Shenghan Lai
An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection.
Annals of internal medicine 1992;117(3):177-83.
1992: Richard D Gelber; William R Lenderking; Deborah Cotton; Bernard F Cole; Margaret A Fischl; Aron Goldhirsch; Marcia A Testa
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group.
Annals of internal medicine 1992;116(12 Pt 1):961-6.
1992: H Z Bass; W D Hardy; Ronald T Mitsuyasu; Jeremy Taylor; Y X Wang; Margaret A Fischl; Stephen A Spector; D D Richman; John L Fahey
The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.
Journal of acquired immune deficiency syndromes 1992;5(3):215-21.
1992: T C Meng; Margaret A Fischl; A M Boota; Stephen A Spector; D Bennett; Y Bassiakos; Shenghan Lai; B Wright; Douglas D Richman
Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
Annals of internal medicine 1992;116(1):13-20.
1991: Stephen W Lagakos; Margaret A Fischl; D S Stein; L Lim; P Volberding
Effects of zidovudine therapy in minority and other subpopulations with early HIV infection.
JAMA : the journal of the American Medical Association 1991;266(19):2709-12.
1991: Margaret A Fischl
Antiretroviral therapy in combination with interferon for AIDS-related Kaposi's sarcoma.
The American journal of medicine 1991;90(4A):2S-7S.
1991: Margaret A Fischl; R B Uttamchandani; L Resnick; Ram P Agarwal; Mary Ann Fletcher; J Patrone-Reese; L Dearmas; J Chidekel; M McCann; M Myers
A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
Journal of acquired immune deficiency syndromes 1991;4(1):1-10.
1991: Margaret A Fischl
New developments in dideoxynucleoside antiretroviral therapy for HIV infection.
AIDS clinical review 1991;():197-214.
1990: S Gagnon; A M Boota; Margaret A Fischl; Horst Baier; O W Kirksey; L La Voie
Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial.
The New England journal of medicine 1990;323(21):1444-50.
1990: Margaret A Fischl; Corette Parker; Carla Pettinelli; M Wulfsohn; M S Hirsch; Ann C Collier; D Antoniskis; M Ho; Douglas D Richman; Edward J Fuchs
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
The New England journal of medicine 1990;323(15):1009-14.
1990: Margaret A Fischl; J E Galpin; J D Levine; J E Groopman; D H Henry; P Kennedy; S Miles; W Robbins; B Starrett; R Zalusky
Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
The New England journal of medicine 1990;322(21):1488-93.
1990: T C Meng; Margaret A Fischl; D D Richman
AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
The American journal of medicine 1990;88(5B):27S-30S.
1990: Margaret A Fischl; Douglas D Richman; N Hansen; Ann C Collier; J T Carey; M F Para; W D Hardy; R Dolin; W G Powderly; J D Allan
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Annals of internal medicine 1990;112(10):727-37.
1989: Margaret A Fischl; Douglas D Richman; D M Causey; M H Grieco; Y Bryson; Donna Mildvan; O L Laskin; J E Groopman; P A Volberding; R T Schooley
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.
JAMA : the journal of the American Medical Association 1989;262(17):2405-10.
1989: Thomas C Merigan; G Skowron; Samuel A Bozzette; D Richman; R Uttamchandani; Margaret A Fischl; R Schooley; M Hirsch; W Soo; Carla Pettinelli
Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.
Annals of internal medicine 1989;110(3):189-94.
1989: Margaret A Fischl
State of antiretroviral therapy with zidovudine.
AIDS (London, England) 1989;3 Suppl 1():S137-43.
1989: Margaret A Fischl
Zidovudine: clinical experience in symptomatic HIV disease.
AIDS clinical review 1989;():221-42.
1988: Arthur Fournier; Gordon M Dickinson; I R Erdfrocht; Timothy Cleary; Margaret A Fischl
Tuberculosis and nontuberculous mycobacteriosis in patients with AIDS.
Chest 1988;93(4):772-5.
1988: Margaret A Fischl; Gordon M Dickinson; L La Voie
Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.
JAMA : the journal of the American Medical Association 1988;259(8):1185-9.
1988: Robert Yarchoan; Carlo Federico Perno; R V Thomas; Raymond W Klecker; J P Allain; R J Wills; N McAtee; Margaret A Fischl; R Dubinsky; M C McNeely
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).
Lancet 1988;1(8577):76-81.
1988: Wade P Parks; E S Parks; Margaret A Fischl; M D Leuther; J P Allain; S Nusinoff-Lehrman; D W Barry; R W Makuch
HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail.
Journal of acquired immune deficiency syndromes 1988;1(2):125-30.
1988: Margaret A Fischl
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
AIDS (London, England) 1988;2 Suppl 1():S143-50.
1988: Robert Yarchoan; R V Thomas; J Grafman; A Wichman; Marinos C Dalakas; N McAtee; G Berg; Margaret A Fischl; Carlo Federico Perno; Raymond W Klecker
Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease.
Annals of neurology 1988;23 Suppl():S82-7.
1987: Douglas D Richman; Margaret A Fischl; M H Grieco; M S Gottlieb; P A Volberding; O L Laskin; John Leedom; J E Groopman; Donna Mildvan; M S Hirsch
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
The New England journal of medicine 1987;317(4):192-7.
1987: Margaret A Fischl; Douglas D Richman; M H Grieco; M S Gottlieb; P A Volberding; O L Laskin; John Leedom; J E Groopman; Donna Mildvan; R T Schooley
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
The New England journal of medicine 1987;317(4):185-91.
1987: J R Berger; L Moskowitz; Margaret A Fischl; R E Kelley
Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome.
Southern medical journal 1987;80(6):683-6.
1987: Margaret A Fischl; Gordon M Dickinson; Gwendolyn B Scott; Nancy Klimas; Mary Ann Fletcher; W Parks
Evaluation of heterosexual partners, children, and household contacts of adults with AIDS.
JAMA : the journal of the American Medical Association 1987;257(5):640-4.
1987: Robert Yarchoan; G Berg; Pim Brouwers; Margaret A Fischl; A R Spitzer; A Wichman; J Grafman; R V Thomas; B Safai; Arturo Brunetti
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine.
Lancet 1987;1(8525):132-5.
1987: Mary Ann Fletcher; G C Baron; M R Ashman; Margaret A Fischl; Nancy Klimas
Use of whole blood methods in assessment of immune parameters in immunodeficiency states.
Diagnostic and clinical immunology 1987;5(2):69-81.
1986: Roland M H Schein; Margaret A Fischl; Arthur Pitchenik; C L Sprung
ICU survival of patients with the acquired immunodeficiency syndrome.
Critical care medicine 1986;14(12):1026-7.
1986: Margaret A Fischl; Gordon M Dickinson
Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome.
Annals of internal medicine 1986;105(4):629.
1986: M Judith Donovan Post; G T Hensley; L B Moskowitz; Margaret A Fischl
Cytomegalic inclusion virus encephalitis in patients with AIDS: CT, clinical, and pathologic correlation.
AJR. American journal of roentgenology 1986;146(6):1229-34.
1986: Margaret A Fischl
Patient tolerance to interferon: clinical and laboratory assessments.
The Medical clinics of North America 1986;Suppl():41-5.
1986: Margaret A Fischl; Gordon M Dickinson; C Sinave; Arthur Pitchenik; Timothy Cleary
Salmonella bacteremia as manifestation of acquired immunodeficiency syndrome.
Archives of internal medicine 1986;146(1):113-5.
1985: J E Greenberg; Margaret A Fischl; J R Berger
Upper airway obstruction secondary to acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Chest 1985;88(4):638-40.
1985: Arthur Pitchenik; T J Spira; R Elie; Margaret A Fischl; J P Getchell; E Arnoux; G D Pierre; A C Laroche; J M Guerin; R Malebranche
Prevalence of HTLV-III/LAV antibodies among Haitians.
The New England journal of medicine 1985;312(26):1705-6.
1985: Margaret A Fischl; Arthur Pitchenik; T J Spira
Tuberculous brain abscess and Toxoplasma encephalitis in a patient with the acquired immunodeficiency syndrome.
JAMA : the journal of the American Medical Association 1985;253(23):3428-30.
1985: Gwendolyn B Scott; Margaret A Fischl; Nancy Klimas; Mary Ann Fletcher; Gordon M Dickinson; R S Levine; Wade P Parks
Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers.
JAMA : the journal of the American Medical Association 1985;253(3):363-6.
1985: Arthur Pitchenik; Margaret A Fischl; M J Saldana
Kaposi's sarcoma of the tracheobronchial tree. Clinical, bronchoscopic, and pathologic features.
Chest 1985;87(1):122-4.
1985: G C Baron; Nancy Klimas; Margaret A Fischl; Mary Ann Fletcher
Decreased natural cell-mediated cytotoxicity per effector cell in acquired immunodeficiency syndrome.
Diagnostic immunology 1985;3(4):197-204.
1984: M E Whiteside; Jamie S Barkin; R G May; S D Weiss; Margaret A Fischl; C L MacLeod
Enteric coccidiosis among patients with the acquired immunodeficiency syndrome.
The American journal of tropical medicine and hygiene 1984;33(6):1065-72.
1984: Arthur Pitchenik; C Cole; B W Russell; Margaret A Fischl; T J Spira; D E Snider
Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida.
Annals of internal medicine 1984;101(5):641-5.
1984: Victoriano Pardo; M Aldana; R M Colton; Margaret A Fischl; D Jaffe; L Moskowitz; G T Hensley; J J Bourgoignie
Glomerular lesions in the acquired immunodeficiency syndrome.
Annals of internal medicine 1984;101(4):429-34.
1984: Margaret A Fischl; Gordon M Dickinson
An acquired immunodeficiency syndrome among Haitians: an update.
Annals of the New York Academy of Sciences 1984;437():325-33.
1983: Arthur Pitchenik; Margaret A Fischl; T J Spira
Acquired immune deficiency syndrome in low-risk patients. Evidence for possible transmission by an asymptomatic carrier.
JAMA : the journal of the American Medical Association 1983;250(10):1310-2.
1983: Arthur Pitchenik; Margaret A Fischl; K W Walls
Evaluation of cerebral mass lesions in acquired immunodeficiency syndrome.
The New England journal of medicine 1983;308(18):1099.
1983: A E Pitchenick; Margaret A Fischl
Prevention of acquired immunodeficiency syndrome.
Annals of internal medicine 1983;98(4):558-9.
1983: Arthur Pitchenik; Margaret A Fischl; Gordon M Dickinson; D M Becker; Arthur Fournier; Mark T O'Connell; R M Colton; T J Spira
Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state.
Annals of internal medicine 1983;98(3):277-84.
1983: Arthur Pitchenik; Margaret A Fischl
Disseminated tuberculosis and the acquired immunodeficiency syndrome.
Annals of internal medicine 1983;98(1):112.
1981: Margaret A Fischl; Arthur Pitchenik; L B Gardner
An index predicting relapse and need for hospitalization in patients with acute bronchial asthma.
The New England journal of medicine 1981;305(14):783-9.